Suggested Books and Articles
Thase, M. E. (2005). Bipolar depression: Issues in diagnosis and treatment. Harvard Review of Psychiatry, 13, 257-271 10.1080 /10673220500326425.
A commentary on "Sleep disturbance in bipolar disorder across the lifespan."
Thase, Michael E. Clinical Psychology: Science and Practice. Vol 16(2), Jun 2009, pp. 278-280
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: A pooled analysis of 2 studies. Fava, Maurizio1; Wisniewski, Stephen R.2;Thase, Michael E.3; Baker, Ross A.4; Tran, Quynh-Van5; Pikalov, Andrei5; Yang, Huyuan4; Marcus, Ronald N.6; Berman, Robert M.6 Journal of Clinical Psychopharmacology. Vol 29(4), Aug 2009, pp. 362-367
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Denton, W. H.1; Carmody, T. J.1; Rush, A. J.1; Thase, M. E.2; Trivedi, M. H.1; Arnow, B. A.3; Klein, D. N.4; Keller, M. B.5 Psychological Medicine: A Journal of Research in Psychiatry and the Allied Sciences. Vol 40(3), Mar 2010, pp. 415-424
Gooneratne, N.S., Gehrman, P.R., Nkwuo, J.E., Bellamy, S.L., Schutte-Rodin, S., Dinges, D.F., Pack, A.I. (2006). Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects. Archives of Internal Medicine, 166(16): 1732-1738.
Perlis, M, Gehrman, P, Riemann, D. (2008). Intermittent and long-term dosing of sedative hypnotics. Current Pharmaceutical Design, 14(32):3456-65.
Physician Withdrawal Checklist (PWC-20). Rickels, Karl1; Garcia-Espana, Felipe1; Mandos, Laura A.1; Case, George W.1 Journal of Clinical Psychopharmacology. Vol 28(4), Aug 2008, pp. 447-451
Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: A randomized, double blind, placebo-controlled trial.
Rickels, Karl1; Athanasiou, Maria2; Robinson, Donald S.3; Gibertini, Michael4; Whalen, Heidi2; Reed, Carol R.2 Journal of Clinical Psychiatry. Vol 70(3), Mar 2009, pp. 326-333
Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. Lydiard, R. Bruce1; Rickels, Karl2; Herman, Barry3; Feltner, Douglas E.3 International Journal of Neuropsychopharmacology. Vol 13(2), Mar 2010, pp. 229-241
Early response and 8-week treatment outcome in GAD. Rynn, Moira1; Khalid-Khan, Sarosh1; Garcia-Espana, J. Felipe1; Etemad, Bijan1; Rickels, Karl1 Depression and Anxiety. Vol 23(8), 2006, pp. 461-465
Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder. Lohoff, Falk W.1; Weller, Andrew E.1; Bloch, Paul J.1; Nail, Aleksandra H.1; Ferraro, Thomas N.1; Berrettini, Wade H.1 Journal of Neural Transmission. Vol 115(9), Sep 2008, pp. 1339-1345
Pharmacogenetics of major depressive disorder. Lohoff, Falk W.1 Psychiatric Annals. Vol 38(6), Jun 2008, pp. 414-417
Gehrman, PR, Connor, DJ, Martin, JL, Shochat, T, Corey-Bloom, J, Ancoli-Israel, S. Melatonin fails to improve sleep or agitation in a double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer's disease. American Journal of Geriatric Psychiatry, in press.
Harb, GC, Cook, JM, Gehrman, PR, Gamble, GM, Ross, RJ. (in press). PTSD nightmares and sleep disturbance in Iraq war veterans: A feasible and promising treatment combination. Journal of Psychological Trauma.
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.Barber JP, Barrett MS, Gallop R, Rynn MA, Rickels K.J Clin Psychiatry. 2011 Nov 29.
Back to Top